Literature DB >> 16570739

Retinoblastoma.

Alex Melamud1, Rakhee Palekar, Arun Singh.   

Abstract

Retinoblastoma, a neuroblastic tumor, is the most common primary intraocular malignancy of childhood. Patients usually present with leukokoria (white reflex or white pupil), detected in primary care. The mean age at diagnosis is 12 months for bilateral tumors and 24 months for unilateral tumors. If untreated, almost all patients die of intracranial extension and disseminated disease within two years. However, new diagnostic and treatment methods allow for a high cure rate (93 percent five-year survival in the United States), therefore it is important that primary care physicians recognize the manifestations of this malignancy. Diagnosis is primarily by history and complete ophthalmic examination, with studies including ultrasonography of the eye and imaging of the orbits and brain. Treatment modalities include laser thermotherapy, cryotherapy, radioactive plaques, external beam radiotherapy, chemotherapy, and enucleation. Prospective parents with a family history of retinoblastoma should be referred for genetic counseling. Office evaluation for a red reflex in children should be performed until three years of age. If leukokoria is observed, the patient should be examined by an ophthalmologist within one week.

Entities:  

Mesh:

Year:  2006        PMID: 16570739

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

1.  Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma.

Authors:  Shizheng Su; Jian Gao; Tao Wang; Ju Wang; Hong Li; Zhen Wang
Journal:  Tumour Biol       Date:  2015-04-19

2.  c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells.

Authors:  Zhen Chen; Anhuai Yang; Chong Xu; Yiqiao Xing; Wenrong Gong; Junping Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

3.  Epidemiology and Rb1 gene of retinoblastoma.

Authors:  Jun Yun; Yang Li; Chang-Tai Xu; Bo-Rong Pan
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

4.  [Retinoblastoma in Kenya: survival and prognostic factors].

Authors:  E N Gichigo; M M Kariuki-Wanyoike; K Kimani; M M Nentwich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

5.  Analysis of retinoblastoma age incidence data using a fully stochastic cancer model.

Authors:  Mark P Little; Ruth A Kleinerman; Charles A Stiller; Guangquan Li; Mary E Kroll; Michael F G Murphy
Journal:  Int J Cancer       Date:  2011-06-10       Impact factor: 7.396

6.  Constitutional retinoblastoma gene deletion in Egyptian patients.

Authors:  Amal M Mohammed; Alaa K Kamel; Saida A Hammad; Hanan H Afifi; Zeinab El Sanabary; Mostafa Ezz El Din
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

7.  Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line.

Authors:  Doris Hendig; Thomas Langmann; Ralf Zarbock; Gerd Schmitz; Knut Kleesiek; Christian Götting
Journal:  Mol Cell Biochem       Date:  2009-03-06       Impact factor: 3.396

Review 8.  The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.

Authors:  Xiu-Fen Liu; Ji-Long Hao; Tian Xie; Om Prakash Pant; Cheng-Bo Lu; Cheng-Wei Lu; Dan-Dan Zhou
Journal:  Cell Prolif       Date:  2018-02-27       Impact factor: 6.831

9.  In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.

Authors:  Riccardo Di Fiore; Rosa Drago-Ferrante; Antonella D'Anneo; Giuseppa Augello; Daniela Carlisi; Anna De Blasio; Michela Giuliano; Giovanni Tesoriere; Renza Vento
Journal:  Cancer Biol Ther       Date:  2013-08-12       Impact factor: 4.742

10.  Bilateral Retinoblastoma Presenting in an in vitro Fertilization Infant with Retinopathy of Prematurity.

Authors:  Ruba Saleh Alghofaili; Saleh A Almesfer
Journal:  Case Rep Ophthalmol       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.